{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-21-003192","form_type":"8-K","ticker":"BDPT","cik":"0001575142","company_name":"BIOADAPTIVES, INC.","filed_at":"2021-12-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.104227+00:00","generated_at":"2026-06-28T00:31:49.436166+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"medium","headline":"BioAdaptives enters marketing agreement for LungFlute medical device; plans LungArmor package","bullets":["Marketing agreement with Acoustic Innovations LLC for LungFlute™ OscPEP device; rights in US, Canada, and other approved regions.","Device is FDA-cleared, creates low-frequency acoustic energy to loosen mucus; used in $800K TB trial in Africa.","BioAdaptives to market device as LungCleanser™ combined with PrimiLungs™ supplement as LungArmor™ package.","No financial terms of the agreement disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-21-003192","json":"https://secwatch.observer/filing/0001640334-21-003192.json","markdown":"https://secwatch.observer/filing/0001640334-21-003192.md","text":"https://secwatch.observer/filing/0001640334-21-003192.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1575142/000164033421003192/0001640334-21-003192-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1575142/000164033421003192/bdpt_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T00:31:49.436166+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}